In breast cancer, mutant p53 up-regulates mevalonate pathway components at least in part through the sterol regulatory element-binding proteins (SREBP) family of transcription factors, and increased mevalonate pathway flux is necessary and sufficient for the mutant p53 phenotype observed in culture (42). Here, TP53 is linked to breast carcinoma.